CHAMPIONS ONCOLOGY, INC. — Investor Relations & Filings
Champions Oncology, Inc. is a technology-enabled contract research organization (CRO) providing end-to-end solutions to accelerate oncology drug development. The company partners with pharmaceutical and biotechnology firms, offering a range of preclinical and clinical research services. Its core offering is an extensive, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models used for in vivo and ex vivo efficacy studies. These models are supported by a comprehensive multi-omic data platform that provides genomic, transcriptomic, and proteomic insights for model selection and biomarker discovery. Additionally, Champions Oncology operates as a clinical specialty laboratory, providing advanced analytical services such as high-complexity flow cytometry, next-generation sequencing, and histology to support clinical trials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer) | 2026-03-30 | English | |
| 10-Q | 2026-03-12 | English | |
| 8-K | 2026-03-12 | English | |
| 4 Filing | 2026-01-30 | English | |
| 4 Filing | 2026-01-30 | English | |
| 3 Filing | 2026-01-16 | English |
Browse filings by year
32 years- 2026 6 filings
- 2025 25 filings
- 2024 32 filings
- 2023 42 filings
- 2022 17 filings
- 2021 22 filings
- 2020 34 filings
- 2019 89 filings
- 2018 242 filings
- 2017 60 filings
- 2016 50 filings
- 2015 71 filings
- 2014 24 filings
- 2013 42 filings
- 2012 15 filings
- 2011 30 filings
- 2010 24 filings
- 2009 33 filings
- 2008 22 filings
- 2007 22 filings
- 2006 6 filings
- 2005 10 filings
- 2004 10 filings
- 2003 6 filings
- 2002 5 filings
- 2001 4 filings
- 2000 4 filings
- 1999 5 filings
- 1998 4 filings
- 1997 6 filings
- 1996 7 filings
- 1995 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 33091546 | 8-K - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer) | 2026-03-30 | English | ||
| 46091880 | 10-Q | 2026-03-12 | English | ||
| 46091891 | 8-K | 2026-03-12 | English | ||
| 18555215 | 4 Filing | 2026-01-30 | English | ||
| 18555185 | 4 Filing | 2026-01-30 | English | ||
| 18555204 | 3 Filing | 2026-01-16 | English | ||
|
2025
9 filings
| |||||
| 18555210 | 8-K Filing | 2025-12-15 | English | ||
| 18555172 | 10-Q Filing | 2025-12-15 | English | ||
| 9535731 | FORM 4 | 2025-11-07 | English | ||
| 9535739 | FORM 4 | 2025-11-07 | English | ||
| 9535736 | FORM 4 | 2025-11-07 | English | ||
| 9535733 | FORM 4 | 2025-11-07 | English | ||
| 9535738 | FORM 4 | 2025-11-07 | English | ||
| 9535732 | FORM 4 | 2025-11-06 | English | ||
| 9535734 | 8-K | 2025-10-16 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
CHAMPIONS ONCOLOGY, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/10828/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=10828 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=10828 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=10828 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 10828}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHAMPIONS ONCOLOGY, INC. (id: 10828)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.